Taipei, Taiwan

Wei-Chung Chiou

USPTO Granted Patents = 1 

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Wei-Chung Chiou in the Fight Against Coronavirus

Introduction

Wei-Chung Chiou is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical science, particularly in the development of compounds aimed at combating viral infections. His work is especially relevant in the context of the ongoing global health challenges posed by coronaviruses.

Latest Patents

Wei-Chung Chiou holds a patent for "Compounds and methods for prevention and treatment of coronavirus infections." This invention pertains to anti-coronaviral compounds and includes a method for preventing and/or treating a coronavirus infection through the inhibition of a cysteine protease in a virus, particularly SARS-COV-2. The patent also covers the composition and pharmaceutical composition for preventing and/or treating a coronavirus infection, comprising any of the compounds, pharmaceutically acceptable salts thereof, or their mixtures.

Career Highlights

Chiou is associated with Arjil Biotech Holding Company Limited, where he applies his expertise in biotechnology to develop innovative solutions for health-related issues. His work has garnered attention for its potential impact on public health, especially during times of viral outbreaks.

Collaborations

Some of his notable coworkers include Jir-Mehng Lo and Cheng Huang, who contribute to the collaborative efforts in research and development within the company.

Conclusion

Wei-Chung Chiou's innovative work in developing anti-coronaviral compounds highlights the importance of scientific research in addressing global health challenges. His contributions are vital in the ongoing fight against coronavirus infections, showcasing the role of inventors in advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…